244 related articles for article (PubMed ID: 19020388)
41. The relationship between glucocorticoid replacement and quality of life in 2737 hypopituitary patients.
Ragnarsson O; Mattsson AF; Monson JP; Filipsson Nyström H; Åkerblad AC; Kołtowska-Häggström M; Johannsson G
Eur J Endocrinol; 2014 Nov; 171(5):571-9. PubMed ID: 25127712
[TBL] [Abstract][Full Text] [Related]
42. Management of Childhood-onset Craniopharyngioma in Italy: A Multicenter, 7-Year Follow-up Study of 145 Patients.
Zucchini S; Di Iorgi N; Pozzobon G; Pedicelli S; Parpagnoli M; Driul D; Matarazzo P; Baronio F; Crocco M; Iudica G; Partenope C; Nardini B; Ubertini G; Menardi R; Guzzetti C; Iughetti L; Aversa T; Di Mase R; Cassio A;
J Clin Endocrinol Metab; 2022 Feb; 107(3):e1020-e1031. PubMed ID: 34718649
[TBL] [Abstract][Full Text] [Related]
43. Registries as a tool in evidence-based medicine: example of KIMS (Pfizer International Metabolic Database).
Gutiérrez LP; Kołtowska-Häggström M; Jönsson PJ; Mattsson AF; Svensson D; Westberg B; Luger A
Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):90-102. PubMed ID: 17957812
[TBL] [Abstract][Full Text] [Related]
44. GH and Childhood-onset Craniopharyngioma: When to Initiate GH Replacement Therapy?
Nguyen Quoc A; Beccaria K; González Briceño L; Pinto G; Samara-Boustani D; Stoupa A; Beltrand J; Besançon A; Thalassinos C; Puget S; Blauwblomme T; Alapetite C; Bolle S; Doz F; Grill J; Dufour C; Bourdeaut F; Abbou S; Guerrini-Rousseau L; Leruste A; Brabant S; Cavadias I; Viaud M; Boddaert N; Polak M; Kariyawasam D
J Clin Endocrinol Metab; 2023 Jul; 108(8):1929-1936. PubMed ID: 36794424
[TBL] [Abstract][Full Text] [Related]
45. Quality of life in congenital, untreated, lifetime isolated growth hormone deficiency.
Barbosa JA; Salvatori R; Oliveira CR; Pereira RM; Farias CT; Britto AV; Farias NT; Blackford A; Aguiar-Oliveira MH
Psychoneuroendocrinology; 2009 Jul; 34(6):894-900. PubMed ID: 19181452
[TBL] [Abstract][Full Text] [Related]
46. Endocrine aspects and sequel in patients with craniopharyngioma.
Erfurth EM
J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):19-26. PubMed ID: 25514328
[TBL] [Abstract][Full Text] [Related]
47. Intracavitary chemotherapy of polycystic craniopharyngioma with bleomycin.
Savas A; Arasil E; Batay F; Selcuki M; Kanpolat Y
Acta Neurochir (Wien); 1999; 141(5):547-8; discussion 549. PubMed ID: 10392216
[No Abstract] [Full Text] [Related]
48. Replacement therapy and cardiovascular diseases.
Boschetti M; Goglia U; Teti C; Esposito D; Giusti M; Minuto F; Ferone D
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):85-90. PubMed ID: 19020394
[TBL] [Abstract][Full Text] [Related]
49. [Pre- and postoperative endocrine function in children with craniopharyngioma ].
Lucas C; Benderitter T; Choux M
Arch Fr Pediatr; 1982 May; 39(5):303-7. PubMed ID: 7125828
[TBL] [Abstract][Full Text] [Related]
50. Analysis of short- and long-term metabolic effects of growth hormone replacement therapy in adult patients with craniopharyngioma and non-functioning pituitary adenoma.
Profka E; Giavoli C; Bergamaschi S; Ferrante E; Malchiodi E; Sala E; Verrua E; Rodari G; Filopanti M; Beck-Peccoz P; Spada A
J Endocrinol Invest; 2015 Apr; 38(4):413-20. PubMed ID: 25330765
[TBL] [Abstract][Full Text] [Related]
51. Clinical characteristics of Japanese adults with growth hormone deficiency: a HypoCCS database study.
Shimatsu A; Tai S; Tanaka T; Fujieda K; Teramoto A; Chihara K
Endocr J; 2011; 58(5):325-33. PubMed ID: 21467694
[TBL] [Abstract][Full Text] [Related]
52. Headache, idiopathic intracranial hypertension and slipped capital femoral epiphysis during growth hormone treatment: a safety update from the KIGS database.
Darendeliler F; Karagiannis G; Wilton P
Horm Res; 2007; 68 Suppl 5():41-7. PubMed ID: 18174706
[TBL] [Abstract][Full Text] [Related]
53. Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database).
Darendeliler F; Karagiannis G; Wilton P; Ranke MB; Albertsson-Wikland K; Anthony Price D; On Behalf Of The Kigs International Board
Acta Paediatr; 2006 Oct; 95(10):1284-90. PubMed ID: 16982503
[TBL] [Abstract][Full Text] [Related]
54. Transition from paediatric to adult endocrinology: hypopituitarism.
Stanhope R
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S85-8. PubMed ID: 15135784
[TBL] [Abstract][Full Text] [Related]
55. [Growth hormone deficiency in adults].
Krysiak R; Okopień B
Przegl Lek; 2007; 64(9):583-9. PubMed ID: 18510080
[TBL] [Abstract][Full Text] [Related]
56. Benefits and risks evaluation of recombinant human growth hormone replacement therapy in children with GHD after craniopharyngioma surgery.
Pei LL; Guo Y; Chen H; Zhong LY
J Pediatr Endocrinol Metab; 2023 May; 36(5):484-491. PubMed ID: 36935568
[TBL] [Abstract][Full Text] [Related]
57. Cross-sectional analysis of testosterone therapies in hypopituitary men on stable pituitary hormone replacement.
Siyambalapitiya S; Jonsson P; Koltowska-Haggstrom M; Gaillard R; Ho K; Ross RJ
Clin Endocrinol (Oxf); 2009 Jun; 70(6):907-13. PubMed ID: 18823394
[TBL] [Abstract][Full Text] [Related]
58. [Diagnosis and treatment of adult growth hormone deficiency (aGHD) resulting from brain injury--role of aGHD].
Arita K; Hirano H; Tominaga A; Kurisu K
Brain Nerve; 2008 Dec; 60(12):1445-54. PubMed ID: 19110756
[TBL] [Abstract][Full Text] [Related]
59. Endocrine and growth features in childhood craniopharyngioma: a mono-institutional study.
Di Battista E; Naselli A; Queirolo S; Gallarotti F; Garré ML; Milanaccio C; Cama A
J Pediatr Endocrinol Metab; 2006 Apr; 19 Suppl 1():431-7. PubMed ID: 16700321
[TBL] [Abstract][Full Text] [Related]
60. Concomitant therapies (glucocorticoids and sex hormones) in adult patients with growth hormone deficiency.
Scaroni C; Ceccato F; Rizzati S; Mantero F
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):61-5. PubMed ID: 19020389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
